Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Frontotemporal Dementia | 10 | 2022 | 246 | 1.290 |
Why?
|
Alzheimer Disease | 15 | 2024 | 8545 | 1.290 |
Why?
|
Frontotemporal Lobar Degeneration | 6 | 2022 | 102 | 1.070 |
Why?
|
Aphasia, Primary Progressive | 4 | 2020 | 83 | 1.000 |
Why?
|
Atrophy | 11 | 2023 | 1627 | 0.810 |
Why?
|
tau Proteins | 10 | 2023 | 2085 | 0.660 |
Why?
|
Lewy Body Disease | 1 | 2022 | 252 | 0.650 |
Why?
|
Deglutition Disorders | 1 | 2023 | 626 | 0.550 |
Why?
|
Dementia | 5 | 2019 | 2649 | 0.530 |
Why?
|
Cerebral Cortex | 7 | 2021 | 5756 | 0.510 |
Why?
|
Supranuclear Palsy, Progressive | 3 | 2022 | 80 | 0.500 |
Why?
|
Creutzfeldt-Jakob Syndrome | 2 | 2012 | 92 | 0.470 |
Why?
|
Neuropsychological Tests | 11 | 2020 | 7024 | 0.450 |
Why?
|
Prions | 2 | 2012 | 179 | 0.440 |
Why?
|
Pattern Recognition, Visual | 1 | 2019 | 810 | 0.440 |
Why?
|
Amyloid beta-Peptides | 3 | 2023 | 3826 | 0.420 |
Why?
|
Neurodegenerative Diseases | 3 | 2022 | 1081 | 0.350 |
Why?
|
Parkinson Disease | 1 | 2022 | 2864 | 0.290 |
Why?
|
Epilepsy | 1 | 2023 | 3270 | 0.290 |
Why?
|
Memory Disorders | 3 | 2023 | 1198 | 0.240 |
Why?
|
Positron-Emission Tomography | 5 | 2023 | 6457 | 0.230 |
Why?
|
Bacteroides | 1 | 2024 | 166 | 0.220 |
Why?
|
Recreation | 1 | 2024 | 119 | 0.220 |
Why?
|
Water Microbiology | 1 | 2024 | 113 | 0.220 |
Why?
|
Communicable Diseases | 1 | 2011 | 876 | 0.210 |
Why?
|
Pick Disease of the Brain | 1 | 2022 | 42 | 0.200 |
Why?
|
Executive Function | 3 | 2020 | 1375 | 0.200 |
Why?
|
Brain | 13 | 2023 | 26952 | 0.190 |
Why?
|
Aging | 4 | 2018 | 8654 | 0.190 |
Why?
|
Amnesia | 1 | 2023 | 255 | 0.180 |
Why?
|
Organic Chemicals | 1 | 2021 | 211 | 0.180 |
Why?
|
Haploinsufficiency | 1 | 2021 | 327 | 0.170 |
Why?
|
Lyme Neuroborreliosis | 1 | 2020 | 50 | 0.170 |
Why?
|
Genetic Predisposition to Disease | 5 | 2020 | 17767 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 16 | 2023 | 36270 | 0.160 |
Why?
|
Carbolines | 2 | 2017 | 286 | 0.150 |
Why?
|
Memory, Short-Term | 2 | 2018 | 980 | 0.150 |
Why?
|
Hyperthyroidism | 1 | 2020 | 291 | 0.150 |
Why?
|
Amyloid | 1 | 2023 | 839 | 0.150 |
Why?
|
Occipital Lobe | 1 | 2019 | 373 | 0.150 |
Why?
|
Perceptual Disorders | 1 | 2019 | 197 | 0.140 |
Why?
|
Hyponatremia | 1 | 2020 | 279 | 0.140 |
Why?
|
Middle Aged | 27 | 2024 | 219192 | 0.140 |
Why?
|
Aged | 21 | 2024 | 167890 | 0.140 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2021 | 772 | 0.130 |
Why?
|
Humans | 45 | 2024 | 757566 | 0.120 |
Why?
|
Geniculate Bodies | 1 | 2015 | 154 | 0.120 |
Why?
|
REM Sleep Behavior Disorder | 1 | 2015 | 108 | 0.120 |
Why?
|
Pons | 1 | 2015 | 239 | 0.120 |
Why?
|
Disease Progression | 5 | 2020 | 13463 | 0.120 |
Why?
|
Mutation | 6 | 2022 | 29929 | 0.120 |
Why?
|
Language | 2 | 2022 | 1529 | 0.110 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2018 | 388 | 0.110 |
Why?
|
Cognition | 3 | 2021 | 6952 | 0.110 |
Why?
|
Basal Ganglia | 1 | 2016 | 553 | 0.110 |
Why?
|
Male | 31 | 2024 | 358180 | 0.110 |
Why?
|
Hallucinations | 1 | 2015 | 366 | 0.110 |
Why?
|
Female | 30 | 2024 | 389943 | 0.100 |
Why?
|
Vision Disorders | 1 | 2019 | 1084 | 0.100 |
Why?
|
Mental Recall | 1 | 2018 | 1209 | 0.100 |
Why?
|
Psychology | 1 | 2013 | 355 | 0.090 |
Why?
|
Cost of Illness | 1 | 2020 | 1925 | 0.090 |
Why?
|
Fatal Outcome | 2 | 2012 | 1828 | 0.090 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2020 | 8946 | 0.090 |
Why?
|
Event-Related Potentials, P300 | 1 | 2010 | 149 | 0.080 |
Why?
|
Glucuronates | 1 | 1988 | 40 | 0.080 |
Why?
|
Field Dependence-Independence | 1 | 2008 | 24 | 0.080 |
Why?
|
Caregivers | 1 | 2020 | 2224 | 0.080 |
Why?
|
Visual Cortex | 1 | 2015 | 1089 | 0.070 |
Why?
|
Glycosphingolipids | 1 | 1988 | 73 | 0.070 |
Why?
|
Myelin Proteins | 1 | 1988 | 209 | 0.070 |
Why?
|
Aged, 80 and over | 9 | 2020 | 58558 | 0.070 |
Why?
|
Exploratory Behavior | 1 | 2008 | 273 | 0.070 |
Why?
|
Evoked Potentials, Visual | 1 | 2008 | 415 | 0.060 |
Why?
|
Paraproteinemias | 1 | 1988 | 246 | 0.060 |
Why?
|
Nerve Net | 2 | 2015 | 2264 | 0.060 |
Why?
|
Sewage | 1 | 2024 | 41 | 0.060 |
Why?
|
Norovirus | 1 | 2024 | 36 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2019 | 12951 | 0.060 |
Why?
|
Motor Cortex | 1 | 2011 | 997 | 0.060 |
Why?
|
Reaction Time | 1 | 2010 | 2076 | 0.060 |
Why?
|
Longitudinal Studies | 4 | 2020 | 14473 | 0.060 |
Why?
|
Quality of Life | 2 | 2022 | 13263 | 0.050 |
Why?
|
Psychomotor Performance | 1 | 2010 | 1878 | 0.050 |
Why?
|
Cities | 1 | 2024 | 541 | 0.050 |
Why?
|
Physicians | 2 | 2024 | 4577 | 0.050 |
Why?
|
Biological Availability | 1 | 2021 | 390 | 0.050 |
Why?
|
Awareness | 1 | 2024 | 642 | 0.040 |
Why?
|
Tomography, Emission-Computed | 2 | 2000 | 1121 | 0.040 |
Why?
|
Memory | 1 | 2008 | 2179 | 0.040 |
Why?
|
Psychomotor Disorders | 1 | 2019 | 149 | 0.040 |
Why?
|
Language Disorders | 1 | 2019 | 138 | 0.040 |
Why?
|
Anxiety | 3 | 2023 | 4532 | 0.040 |
Why?
|
Limbic System | 1 | 2000 | 419 | 0.040 |
Why?
|
Environmental Monitoring | 1 | 2024 | 1445 | 0.040 |
Why?
|
Attention | 1 | 2008 | 2387 | 0.040 |
Why?
|
Adult | 11 | 2021 | 219725 | 0.040 |
Why?
|
Nervous System Diseases | 1 | 1988 | 1649 | 0.040 |
Why?
|
Deoxyglucose | 1 | 1997 | 333 | 0.030 |
Why?
|
Visual Perception | 2 | 2019 | 1374 | 0.030 |
Why?
|
North America | 1 | 2020 | 1273 | 0.030 |
Why?
|
Brain Mapping | 1 | 2011 | 6571 | 0.030 |
Why?
|
Syndrome | 1 | 2022 | 3261 | 0.030 |
Why?
|
Verbal Learning | 1 | 2018 | 463 | 0.030 |
Why?
|
Social Behavior | 1 | 2022 | 1132 | 0.030 |
Why?
|
Checklist | 1 | 2022 | 827 | 0.030 |
Why?
|
Water Deprivation | 1 | 1994 | 19 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 25924 | 0.030 |
Why?
|
Young Adult | 4 | 2020 | 58755 | 0.030 |
Why?
|
Receptors, Glutamate | 1 | 1994 | 228 | 0.030 |
Why?
|
Cohort Studies | 3 | 2022 | 41190 | 0.030 |
Why?
|
Immunoglobulin M | 2 | 1988 | 1530 | 0.030 |
Why?
|
Parietal Lobe | 1 | 2018 | 849 | 0.030 |
Why?
|
Heterozygote | 1 | 2019 | 2797 | 0.030 |
Why?
|
Language Tests | 1 | 2013 | 190 | 0.030 |
Why?
|
Adolescent | 4 | 2020 | 87819 | 0.030 |
Why?
|
Age of Onset | 1 | 2019 | 3296 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2020 | 1688 | 0.030 |
Why?
|
Visual Pathways | 1 | 2015 | 534 | 0.020 |
Why?
|
Reference Values | 3 | 2008 | 4918 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2847 | 0.020 |
Why?
|
Gyrus Cinguli | 1 | 1997 | 1115 | 0.020 |
Why?
|
Animals | 3 | 2013 | 167718 | 0.020 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2020 | 1309 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2018 | 1825 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2000 | 2725 | 0.020 |
Why?
|
Hypothalamus | 1 | 1994 | 998 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2013 | 1567 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2019 | 2387 | 0.020 |
Why?
|
Polysomnography | 1 | 2015 | 1825 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2495 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2018 | 1882 | 0.020 |
Why?
|
Glucuronic Acid | 1 | 1988 | 150 | 0.020 |
Why?
|
Myelin-Associated Glycoprotein | 1 | 1988 | 107 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2782 | 0.020 |
Why?
|
Gangliosides | 1 | 1988 | 132 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2634 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2599 | 0.020 |
Why?
|
Frontal Lobe | 1 | 2013 | 1419 | 0.020 |
Why?
|
Oligosaccharides | 1 | 1988 | 403 | 0.020 |
Why?
|
Neuromuscular Diseases | 1 | 1988 | 255 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2019 | 3975 | 0.020 |
Why?
|
Seizures | 1 | 2018 | 2919 | 0.020 |
Why?
|
Glucose | 1 | 1997 | 4336 | 0.020 |
Why?
|
Semantics | 1 | 2008 | 601 | 0.010 |
Why?
|
Task Performance and Analysis | 1 | 2008 | 759 | 0.010 |
Why?
|
Depressive Disorder | 1 | 1997 | 3726 | 0.010 |
Why?
|
Photic Stimulation | 1 | 2010 | 1967 | 0.010 |
Why?
|
Motor Neurons | 1 | 1988 | 864 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18326 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 23816 | 0.010 |
Why?
|
Evoked Potentials | 1 | 2008 | 1036 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2015 | 3047 | 0.010 |
Why?
|
Environment | 1 | 2008 | 1117 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15781 | 0.010 |
Why?
|
Depression | 1 | 2000 | 8049 | 0.010 |
Why?
|
Imagination | 1 | 2000 | 226 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2018 | 79984 | 0.010 |
Why?
|
Supraoptic Nucleus | 1 | 1994 | 28 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39020 | 0.010 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1994 | 69 | 0.010 |
Why?
|
Kainic Acid | 1 | 1994 | 198 | 0.010 |
Why?
|
Tritium | 1 | 1994 | 707 | 0.010 |
Why?
|
Putamen | 1 | 1994 | 291 | 0.010 |
Why?
|
Mood Disorders | 1 | 2000 | 1123 | 0.010 |
Why?
|
Globus Pallidus | 1 | 1994 | 250 | 0.010 |
Why?
|
Stroke | 1 | 2015 | 9695 | 0.010 |
Why?
|
Caudate Nucleus | 1 | 1994 | 389 | 0.010 |
Why?
|
Electroencephalography | 1 | 2008 | 6187 | 0.010 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 1994 | 195 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1988 | 9163 | 0.010 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1994 | 892 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1997 | 6230 | 0.000 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 1997 | 2004 | 0.000 |
Why?
|
G(M1) Ganglioside | 1 | 1988 | 87 | 0.000 |
Why?
|
Nerve Tissue | 1 | 1988 | 78 | 0.000 |
Why?
|
Cell Membrane | 1 | 1994 | 3680 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1988 | 2469 | 0.000 |
Why?
|
Epitopes | 1 | 1988 | 2502 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 1997 | 15207 | 0.000 |
Why?
|
Autoantibodies | 1 | 1988 | 2116 | 0.000 |
Why?
|
Rats | 1 | 1994 | 23676 | 0.000 |
Why?
|
Prognosis | 1 | 1997 | 29488 | 0.000 |
Why?
|
Concepts
(183)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(39)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_